SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolargo, Inc. – ‘POS AM’ on 6/22/18 – ‘EX-3.4’

On:  Friday, 6/22/18, at 5:13pm ET   ·   Accession #:  1437749-18-12304   ·   File #:  333-220482

Previous ‘POS AM’:  None   ·   Next:  ‘POS AM’ on 8/28/18   ·   Latest:  ‘POS AM’ on 4/12/24   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/22/18  Biolargo, Inc.                    POS AM                 3:2.8M                                   RDG Filings/FA

Post-Effective Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: POS AM      Post-Effective Amendment                            HTML   1.56M 
 2: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML      7K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      6K 


EX-3.4   —   Articles of Incorporation/Organization or By-Laws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

Exhibit 3.4

 

STATE OF DELAWARE

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

BIOLARGO, INC.

 

 

BioLargo, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

FIRST: That at a meeting of the Board of Directors of BioLargo, Inc., resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said corporation, declaring said amendment to be advisable and calling a meeting of the stockholders of said corporation for consideration thereof. The resolution setting forth the proposed amendment is as follows:

 

RESOLVED, that the Certificate of Incorporation of this corporation be amended by changing the Article thereof numbered “FOURTH” so that, as amended, said Article shall be and read as follows:

 

“FOURTH: The total number of shares of capital stock which the Corporation is authorized to issue is 450,000,000 shares, all with a par value of $0.00067 per share, 400,000,000 shares of which shall be common stock (the “Common Stock”) and 50,000,000 shares of which shall be preferred stock (the “Preferred Stock”).”

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, a special meeting of the stockholders of said corporation was duly called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares as required by statute were voted in favor of the amendment.

 

THIRD: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

IN WITNESS WHEREOF, said corporation has caused this certificate to be signed this 23rd day of May, 2018.

 

 

/S/DENNIS CALVERT

Signed:                                                                                    

Dennis Calvert President

BioLargo, Inc.


30 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Biolargo, Inc.                    S-1                    6:2M                                     RDG Filings/FA
 4/12/24  Biolargo, Inc.                    POS AM                 5:1.8M                                   RDG Filings/FA
 4/12/24  Biolargo, Inc.                    POS AM                 5:1.8M                                   RDG Filings/FA
 4/01/24  Biolargo, Inc.                    10-K       12/31/23   79:9.5M                                   RDG Filings/FA
11/14/23  Biolargo, Inc.                    10-Q        9/30/23   68:8.8M                                   RDG Filings/FA
 8/14/23  Biolargo, Inc.                    10-Q        6/30/23   67:8.6M                                   RDG Filings/FA
 5/17/23  Biolargo, Inc.                    10-Q        3/31/23   70:8.3M                                   RDG Filings/FA
 4/27/23  Biolargo, Inc.                    S-1                    5:1.9M                                   RDG Filings/FA
 4/27/23  Biolargo, Inc.                    POS AM                 3:1.8M                                   RDG Filings/FA
 4/14/23  Biolargo, Inc.                    POS AM                 4:1.8M                                   RDG Filings/FA
 3/31/23  Biolargo, Inc.                    10-K       12/31/22   77:9.4M                                   RDG Filings/FA
 1/11/23  Biolargo, Inc.                    S-1/A                  5:2.6M                                   RDG Filings/FA
12/23/22  Biolargo, Inc.                    S-1                    5:2.7M                                   RDG Filings/FA
11/14/22  Biolargo, Inc.                    10-Q        9/30/22   62:7.5M                                   RDG Filings/FA
 8/15/22  Biolargo, Inc.                    10-Q        6/30/22   60:7.2M                                   RDG Filings/FA
 5/16/22  Biolargo, Inc.                    10-Q        3/31/22   61:6.5M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.9M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.9M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.8M                                   RDG Filings/FA
 3/31/22  Biolargo, Inc.                    10-K       12/31/21   73:9.3M                                   RDG Filings/FA
11/15/21  Biolargo, Inc.                    10-Q        9/30/21   64:8.3M                                   RDG Filings/FA
 8/16/21  Biolargo, Inc.                    10-Q        6/30/21   64:8.1M                                   RDG Filings/FA
 5/17/21  Biolargo, Inc.                    10-Q        3/31/21   64:7M                                     RDG Filings/FA
 4/08/21  Biolargo, Inc.                    POS AM      4/07/21    2:1.9M                                   RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:1.8M                                   RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:2M                                     RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:1.9M                                   RDG Filings/FA
 3/30/21  Biolargo, Inc.                    10-K       12/31/20   73:9.1M                                   RDG Filings/FA
11/16/20  Biolargo, Inc.                    10-Q        9/30/20   61:7.7M                                   RDG Filings/FA
 8/14/20  Biolargo, Inc.                    10-Q        6/30/20   61:7.4M                                   RDG Filings/FA
Top
Filing Submission 0001437749-18-012304   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 12:41:15.1pm ET